InvestorsHub Logo

lasers

01/18/17 8:48 AM

#239472 RE: carbonfiltered #239470

Yes exactly. Califf's FDA now stepping up the ADF approvals. Explains why $ELTP is all excited by the FDA Dec 21 end-of-review for SequestOx.

Exactly why now $ELTP NH PR their Oxycontin ANDA submittal in 2017 as $ELTP is expecting SequestOx approval in early 2017, following which they can then focus on their Oxycontin ANDA submittal.

jour_trader

01/18/17 9:04 AM

#239479 RE: carbonfiltered #239470

Wow! Let's hope FDA applies a consistent framework to all.